• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估艾地骨化醇和阿仑膦酸钠对老年骨质疏松症女性姿势平衡控制的影响。

Assessment of eldecalcitol and alendronate effect on postural balance control in aged women with osteoporosis.

机构信息

Institute of Gerontology, J. F. Oberlin University, 3758 Tokiwa-machi, Machida, 194-0294, Tokyo, Japan.

Department of Orthopedic Surgery, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.

出版信息

J Bone Miner Metab. 2020 Nov;38(6):859-867. doi: 10.1007/s00774-020-01118-w. Epub 2020 Jul 27.

DOI:10.1007/s00774-020-01118-w
PMID:32719981
Abstract

INTRODUCTION

Older people aged over 75 are more prone to falls because physical functions become deteriorated along with aging, and also fracture risk is strongly correlated with age. We evaluated the effects of anti-osteoporosis agents, eldecalcitol (ELD) and alendronate (ALN) on physical functions by assessing dynamic and static postural balance in aged patients with osteoporosis.

MATERIALS AND METHODS

A randomized, open-label, controlled clinical trial has been conducted with 124 female patients aged 65 or over with osteoporosis. Patients were randomly assigned to receive either 0.75 μg of ELD once-a-day or 35 mg of ALN once-a-week for 24 weeks. The primary endpoint was the change in a postural balance index, adjusted composite equilibrium score (CES) of sensory organization test (SOT). The SOT equilibrium scores, leg muscle strength, and other physical functions were also evaluated.

RESULTS

The Adjusted CES increased from baseline by 6.10% in the ELD group and 6.28% in the ALN group. There was no statistically significant difference between the two groups. The static postural balance at fixed platform were maintained in the ELD group, but declined in the ALN group. The dynamic postural balance at swaying platform and knee extension power increased from baseline in both groups.

CONCLUSIONS

These results suggest that ELD and ALN treatments may each be beneficial to improve postural balance control in older patients with osteoporosis via different mechanisms of action.

摘要

简介

75 岁以上的老年人更容易摔倒,因为随着年龄的增长,身体机能会恶化,而且骨折风险与年龄密切相关。我们通过评估骨质疏松症老年患者的动态和静态姿势平衡来评估抗骨质疏松药物艾地骨化醇(ELD)和阿仑膦酸钠(ALN)对身体功能的影响。

材料和方法

对 124 名 65 岁或以上的女性骨质疏松症患者进行了一项随机、开放标签、对照临床试验。患者被随机分为每天一次接受 0.75μg ELD 或每周一次接受 35mg ALN 治疗 24 周。主要终点是姿势平衡指数、感觉组织测试(SOT)调整后的综合平衡评分(CES)的变化。还评估了 SOT 平衡评分、腿部肌肉力量和其他身体功能。

结果

ELD 组的调整后 CES 从基线增加了 6.10%,ALN 组增加了 6.28%。两组之间没有统计学上的显著差异。ELD 组在固定平台上的静态姿势平衡得到维持,而 ALN 组则下降。在摆动平台和膝关节伸展力量方面,两组的动态姿势平衡均从基线开始增加。

结论

这些结果表明,ELD 和 ALN 治疗可能通过不同的作用机制对改善骨质疏松症老年患者的姿势平衡控制都有益处。

相似文献

1
Assessment of eldecalcitol and alendronate effect on postural balance control in aged women with osteoporosis.评估艾地骨化醇和阿仑膦酸钠对老年骨质疏松症女性姿势平衡控制的影响。
J Bone Miner Metab. 2020 Nov;38(6):859-867. doi: 10.1007/s00774-020-01118-w. Epub 2020 Jul 27.
2
Eldecalcitol improves muscle strength and dynamic balance in postmenopausal women with osteoporosis: an open-label randomized controlled study.eldecalcitol改善绝经后骨质疏松症女性的肌肉力量和动态平衡:一项开放标签随机对照研究。
J Bone Miner Metab. 2016 Sep;34(5):547-54. doi: 10.1007/s00774-015-0695-x. Epub 2015 Jul 25.
3
Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.依降钙素与阿仑膦酸钠联合治疗对去卵巢大鼠骨量、力学性能和骨组织形态计量学的影响:与阿尔法骨化醇和阿仑膦酸钠的比较。
Bone. 2013 Jan;52(1):181-8. doi: 10.1016/j.bone.2012.09.031. Epub 2012 Oct 2.
4
Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.在日本原发性骨质疏松症患者中,阿仑膦酸盐(ALN)与新型活性维生素D类似物 eldecalcitol 联合治疗的疗效与 ALN、维生素 D 加钙联合治疗的疗效对比。
Osteoporos Int. 2015 Mar;26(3):1193-202. doi: 10.1007/s00198-014-2991-z. Epub 2015 Jan 16.
5
Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.低剂量阿仑膦酸钠治疗对中国绝经后骨质疏松和骨量减少症妇女骨密度和骨转换标志物的影响。
Menopause. 2013 Jan;20(1):72-8. doi: 10.1097/gme.0b013e31825fe2e8.
6
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial.阿仑膦酸钠联合或不联合胆钙化醇治疗骨质疏松症:一项为期15周的随机对照试验结果
Curr Med Res Opin. 2006 Sep;22(9):1745-55. doi: 10.1185/030079906x120913.
7
Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.阿仑膦酸钠治疗绝经后骨质疏松症时的维生素 D 状态和骨密度变化。
Calcif Tissue Int. 2014 Feb;94(2):153-7. doi: 10.1007/s00223-013-9763-1. Epub 2013 Aug 4.
8
Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.全身振动锻炼对接受阿仑膦酸盐治疗的绝经后骨质疏松女性腰椎骨密度、骨转换及慢性背痛的影响。
Aging Clin Exp Res. 2005 Apr;17(2):157-63. doi: 10.1007/BF03324589.
9
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.口服阿仑膦酸盐可使患有骨质疏松症的绝经后妇女在3年内脊柱、髋部和全身骨量逐步增加。
Bone. 1996 Feb;18(2):141-50. doi: 10.1016/8756-3282(95)00436-x.
10
Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.维生素D缺乏所致继发性甲状旁腺功能亢进影响老年骨质疏松女性对阿仑膦酸钠的骨密度反应:一项随机对照试验
J Am Geriatr Soc. 2007 May;55(5):752-7. doi: 10.1111/j.1532-5415.2007.01161.x.

引用本文的文献

1
Rethinking Osteoporosis Drugs: Can We Simultaneously Address Sarcopenia?重新思考骨质疏松症药物:我们能否同时解决肌肉减少症问题?
Int J Mol Sci. 2025 Jul 18;26(14):6924. doi: 10.3390/ijms26146924.
2
Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence.阿仑膦酸钠联合InterTan治疗骨质疏松性股骨转子间骨折及骨折复发的效果
World J Clin Cases. 2022 Jul 26;10(21):7324-7332. doi: 10.12998/wjcc.v10.i21.7324.
3
Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial.
金天格联合阿法骨化醇改善原发性骨质疏松症患者的肌肉力量和平衡:一项随机、双盲、双模拟、阳性对照、多中心临床试验。
J Orthop Translat. 2022 Aug 24;35:53-61. doi: 10.1016/j.jot.2022.05.002. eCollection 2022 Jul.
4
Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.艾地骨化醇治疗骨质疏松症的疗效和安全性:一项随机对照试验的荟萃分析。
Front Endocrinol (Lausanne). 2022 Apr 19;13:854439. doi: 10.3389/fendo.2022.854439. eCollection 2022.
5
Knockdown of hsa_circ_0001275 reverses dexamethasone-induced osteoblast growth inhibition via mediation of miR-377/CDKN1B axis.敲低 hsa_circ_0001275 通过调控 miR-377/CDKN1B 轴逆转地塞米松诱导的成骨细胞生长抑制。
PLoS One. 2021 May 27;16(5):e0252126. doi: 10.1371/journal.pone.0252126. eCollection 2021.